This study is an open-label nonrandomized exploratory proof of concept and descriptive 4-year immunogenicity study to assess immunogenicity after administration of a 2-dose regimen of 9-valent human papillomavirus vaccine (9vHPV) vaccine separated by 12 months (months 0, 12).
Age range
4 Years – 8 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
HPV6 antibodies at 13 months
Timeframe: 13 months
HPV11 antibodies at 13 months
Timeframe: 13 months
HPV16 antibodies at 13 months
Timeframe: 13 months
HPV18 antibodies at 13 months
Timeframe: 13 months
HPV31 antibodies at 13 months
Timeframe: 13 months
HPV33 antibodies at 13 months
Timeframe: 13 months
HPV45 antibodies at 13 months
Timeframe: 13 months
HPV52 antibodies at 13 months
Timeframe: 13 months
HPV58 antibodies at 13 months
Timeframe: 13 months
HPV6 antibodies at 60 months
Timeframe: 60 months
HPV11 antibodies at 60 months
Timeframe: 60 months
HPV16 antibodies at 60 months
Timeframe: 60 months
HPV18 antibodies at 60 months
Timeframe: 60 months
HPV31 antibodies at 60 months
Timeframe: 60 months
HPV33 antibodies at 60 months
Timeframe: 60 months
HPV45 antibodies at 60 months
Timeframe: 60 months
HPV52 antibodies at 60 months
Timeframe: 60 months
HPV58 antibodies at 60 months
Timeframe: 60 months